March 3, 2026

Transcriptional Control of PI3K/AKT/mTOR by piRNA-651 in Breast Carcinoma.

Key Points

AKT exhibits independence from both PI3K and mTOR due to piR-651 inhibition, indicating a critical shift in cellular signaling.
A notable reduction in breast carcinoma cell proliferation was observed with the inhibition of piR-651 in MCF-7 cells.
The study employed an observational analysis focusing on the effects of piR-651 on signaling pathways in breast carcinoma cells.
The findings highlight potential limitations for using gene therapy targeting piR-651 in estrogen receptor-positive breast cancer cases.

Abstract

piR-651 inhibition causes AKT to behave independently of PI3K and mTOR, particularly in MCF-7 cells, suggesting limited gene therapy potential for estrogen receptor-positive BC. Preliminary data indicate that piR-651 inhibition may reduce BC cell proliferation through effects on PI3K and mTOR.

Mark Helpful

Bookmark

Relay